Navigation Links
Neuralgia Global Clinical Trials Review, H2, 2014
Date:8/5/2014

NEW YORK, Aug. 5, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Neuralgia Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02256143/Neuralgia-Global-Clinical-Trials-Review-H2-2014.html

Neuralgia Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Neuralgia Global Clinical Trials Review, H2, 2014" provides data on the Neuralgia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuralgia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neuralgia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinic
'/>"/>

SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Convergence Pharmaceuticals Announces Successful Interim Data from Ground-Breaking Phase II Trigeminal Neuralgia Study
2. Convergence Pharmaceuticals Announces Start of Phase II Study for Cav2.2 Selective Blocker, CNV2197944 in Pain Associated with Post-Herpetic Neuralgia
3. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
4. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
5. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
6. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
7. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
8. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
9. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
10. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
11. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 2015 The treatment pipeline for ... says  GBI Research . ... Acute Myeloid Leukemia Therapeutics Market to 2020 - forecasts ... moderately from $632.6 million in 2013 to $878.6 million by ... Several drugs to treat AML are expected to ...
(Date:6/3/2015)... SHANGHAI , June 3, 2015 MEDTEC China South ... an extension of MEDTEC China 2015, MEDTEC China South has ... attributes, standing out as a key event for the medical ... After many years of challenges, this year marks the successful return ... 10 years after the event first debuted there in 2005. ...
(Date:6/3/2015)... 2015  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), ... its expertise in opioid antagonists, announced today that ... opioid overdose with intranasal naloxone, has commenced a ... to the United States Food and Drug Administration ... a drug intended to treat opioid overdose.  A ...
Breaking Medicine Technology:Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 2Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 3MEDTEC Successfully Returns to Southern China 2MEDTEC Successfully Returns to Southern China 3Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 3
... MUNDELEIN, Ill. , July 20 ... and information systems technology, today announced the addition of ... Sysmex hematology product offering.  The DM1200 enables Sysmex America ... analysis, which improves both the quality of results and ...
... Mich. , July 20 Two southeast Michigan ... in the region.  Delphinus Medical Technologies and Quantum Signal were approved today for ... of Michigan . , , , ... Arbor region continues to be a magnet for growing, high tech companies," ...
Cached Medicine Technology:Sysmex America Begins Distribution of CellaVision® DM1200 2Sysmex America Begins Distribution of CellaVision® DM1200 3Quantum Signal and Delphinus Medical Technologies Awarded MEGA Funding to Expand in Ann Arbor Area 2Quantum Signal and Delphinus Medical Technologies Awarded MEGA Funding to Expand in Ann Arbor Area 3
(Date:6/3/2015)... On Sunday, June 7, 2015, tens of ... their local communities to observe the 28th annual National ... and abroad will hold celebrations on this day to ... challenges of cancer survivorship, and to show the world ... rewarding, and inspiring.,  , National Cancer Survivors Day® is ...
(Date:6/3/2015)... are challenging and unpredictable times for traditional organizations across ... are rewriting the rules for business as we knew ... businesses to take on a more agile approach in ... On top of this there is a growing trend ... new innovation and approaches to business. , The manager ...
(Date:6/3/2015)... ON (PRWEB) June 03, 2015 On ... a Marketing Authorization (MA), effective immediately, which now permits ... foods that contain oats as ingredients. The MA is ... being developed. All stakeholders should be aware that, unlike ... in the USA, there are restrictions for gluten-free oat ...
(Date:6/3/2015)... Veatch Consulting Services is excited to ... opened for business in April 2006, they have made ... their clients. Each and every year they have worked ... proud to say that they are off to a ... recently added this year is the Customer Review site ...
(Date:6/2/2015)... BALTIMORE, Md. – Ellarea Maria ... about wellness after being diagnosed with lupus. In spite ... lifestyle changes which enhance health, lupus and other autoimmune ... Wellspring for Wellness ,” she offers a holistic approach ... book provides an overview of some autoimmune diseases—especially ...
Breaking Medicine News(10 mins):Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 4Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 3Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3Health News:New book offers holistic approach in living with autoimmune diseases 2Health News:New book offers holistic approach in living with autoimmune diseases 3
... By Amanda Gardner HealthDay Reporter , THURSDAY, March ... that screening for prostate cancer does not substantially reduce the ... hand, a good many men might receive false-positive results and ... researchers report in the March 31 online issue of the ...
... A potential new experimental diagnostic test able to quickly ... latent TB infection has been developed. If the preliminary ... larger population sample, the new diagnostic system could allow ... re-emerging pathology. The work was performed by ...
... system to perform in vivo RNAi screens for ... hepatocyte proliferation during chronic liver damage.1 Functional ... of the candidate gene by different shRNAs can ... and also increase the regenerative capacity of chronically ...
... new TNM 7 lung cancer staging system seems to ... of lung cancer following surgery, according to a study ... of Thoracic Oncology . Being able to better ... important, especially given the controversies surrounding the use of ...
... target for lung cancer has been discovered by researchers at ... the protein AIMP2 is highly expressed in lung cancer cells ... show lower survival. The study is published on March 31 ... Lung cancer is one of the world,s most common cancers ...
... leading cancer organizations shows rates of death in the United States ... 2003 and 2007. The findings come from the latest Annual Report ... report also finds that the overall rate of new cancer diagnoses ... than 1 percent per year for the same period. Edward ...
Cached Medicine News:Health News:Prostate Cancer Screening Doesn't Cut Death Rates: Study 2Health News:Prostate Cancer Screening Doesn't Cut Death Rates: Study 3Health News:A new experimental diagnostic test able to quickly distinguish infection from tuberculosis disease 2Health News:A new experimental diagnostic test able to quickly distinguish infection from tuberculosis disease 3
... With the GE Innova 2100IQ: See the ... legs. Place interventional devices. Its all enabled ... panel that helps deliver excellent image quality ... Innova family systems installed worldwide, more physicians ...
... provides clinically valuable, device-derived information applicable ... to help specialty physicians discern if ... stable or deteriorating. For example, heart ... Medtronic InSync Sentry™ CRT-D system can ...
... (ALS) is a GH dependent protein which is ... acid peptide with a predicted molecular weight of ... confined to a ~150 KDa GH-dependent ternary protein ... or IGF-II, and this unique acid-labile subunit (ALS) ...
... was first identified in 1980 (1) and has ... of appetite (2). PYY is produced by the ... intake, and is found to decrease appetite. The ... the circulation is PYY3-36, the N-terminal truncated form ...
Medicine Products: